Clinical Research Directory
Browse clinical research sites, groups, and studies.
Optimal Timing of Hepatitis B Vaccination After Transplants
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Summary
The investigators aim to perform a randomized clinical trial to determine the optimal timing of hepatitis B vaccination after hematopoietic cell transplantation (HCT) through evaluating the immunity effect of two different vaccination schedules (initiated at 3 or 6 months after transplantation) in patients with different immune reconstitution status.
Official title: Optimal Timing of Hepatitis B Vaccination After Transplants: a Randomized Clinical Study
Key Details
Gender
All
Age Range
16 Years - Any
Study Type
INTERVENTIONAL
Enrollment
1500
Start Date
2025-06-01
Completion Date
2029-03-01
Last Updated
2025-03-21
Healthy Volunteers
No
Interventions
hepatitis B vaccine
Three doses of hepatitis B vaccine
Locations (1)
Institute of Hematology & Blood Diseases Hospital
Tianjin, Tianjin Municipality, China